Apogem Capital’s iRhythm Holdings IRTC Stock Holding History

Apogem Capital’s Portfolio IRTC Stock Details IRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,000	Closed	-$199K	–	195
2021 Q2	$199K	Buy	+3,000	New	+$238K	0.13%	165

Other funds holding IRTC

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Apogem Capital's IRTC Position: Q3 2021 in Review

Apogem Capital sold out of iRhythm Holdings (IRTC) in Q3 2021, closing a stake of 1,588 shares — an estimated $105K sold.

Apogem Capital first reported a position in IRTC in Q2 2021 and held it in 1 quarter. The position peaked at $105K in Q2 2021. 186 funds tracked by Wall St. Rank hold IRTC as of Q3 2021.

Apogem Capital reported no remaining iRhythm Holdings position as of Q3 2021 after selling out during the quarter.
Apogem Capital sold 1,588 iRhythm Holdings shares in Q3 2021, an estimated $105K.
Apogem Capital first reported a position in iRhythm Holdings in Q2 2021 and held it in 1 quarter.
Apogem Capital's iRhythm Holdings position peaked at $105K in Q2 2021.
186 funds tracked by Wall St. Rank held iRhythm Holdings as of Q3 2021.

Based on Apogem Capital's 13F filing for Q3 2021, filed 15 Nov 2021.